The expression of SEC14L2 was significantly lower in some cancers, including bladder urothelial carcinoma, cholangiocarcinoma, kidney chromophobe, lung adenocarcinoma, and HCC. The gene discussed is SEC14L2; the disease is bladder transitional cell carcinoma.